| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/BBRC.2001.4312 |
| P698 | PubMed publication ID | 11237734 |
| P2093 | author name string | Béliveau R | |
| Berthelet F | |||
| Demeule M | |||
| Régina A | |||
| Labelle M | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| multiple drug resistance | Q643839 | ||
| P304 | page(s) | 827-834 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Isolation of endothelial cells from brain, lung, and kidney: expression of the multidrug resistance P-glycoprotein isoforms | |
| P478 | volume | 281 |
| Q34130082 | A novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody. |
| Q36914175 | A review on the relation between the brain-serum concentration ratio of drugs and the influence of P-glycoprotein |
| Q36510891 | ABC drug transporter at the blood-brain barrier: effects on drug metabolism and drug response |
| Q37868835 | ATP-binding cassette transporters and their roles in protecting the brain |
| Q98564393 | Advancing brain barriers RNA sequencing: guidelines from experimental design to publication |
| Q36179624 | Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling |
| Q50778486 | Blood-brain barrier P-glycoprotein function in Alzheimer's disease. |
| Q35913889 | Brain endothelial cells as pharmacological targets in brain tumors |
| Q89834995 | CD38 in Neurodegeneration and Neuroinflammation |
| Q38682530 | Cerebrovascular Angiogenic Reprogramming upon LRP1 Repression: Impact on Sphingosine-1-Phosphate-Mediated Signaling in Brain Endothelial Cell Chemotactism |
| Q47726614 | Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment |
| Q33772891 | Combined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled rats |
| Q60628197 | Corticosteroids and the blood–brain barrier |
| Q36772901 | Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA. |
| Q40602414 | Down-regulation of caveolin-1 in glioma vasculature: modulation by radiotherapy. |
| Q34530624 | Drug efflux transporters in the CNS. |
| Q34515209 | Drug interactions with patient-controlled analgesia |
| Q35046193 | Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier |
| Q84774472 | Epigenetic regulation of the endothelial nitric oxide synthase gene in persistent pulmonary hypertension of the newborn rat |
| Q48264432 | Establishing a method to isolate rat brain capillary endothelial cells by magnetic cell sorting and dominant mRNA expression of multidrug resistance-associated protein 1 and 4 in highly purified rat brain capillary endothelial cells |
| Q33684017 | Expression and clinical significance of multidrug resistance proteins in brain tumors |
| Q48543194 | Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes |
| Q44251866 | Expression of P-glycoprotein in human cerebral cortex microvessels |
| Q45934495 | Expression of genes involved in vascular development and angiogenesis in endothelial cells of adult lung. |
| Q44257019 | Fluoro-, bromo-, and iodopaclitaxel derivatives: synthesis and biological evaluation |
| Q33893813 | Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery? |
| Q44210260 | Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein |
| Q49014147 | Inhibition of P-glycoprotein over-expression by shRNA-mdr1b in rat astrocytes |
| Q40749836 | Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols |
| Q40682250 | Interaction of immunosuppressive agents rapamycin and its analogue SDZ-RAD with endothelial P-gp |
| Q46660264 | Ischemia injury alters endothelial cell properties of kidney cortex: stimulation of MMP-9. |
| Q41069470 | Isolation and culture of pulmonary endothelial cells from neonatal mice |
| Q34659563 | Isolation and epithelial co-culture of mouse renal peritubular endothelial cells |
| Q53028911 | Isolation of endothelial cells from mouse lung. |
| Q37218065 | Isolation of murine lung endothelial cells |
| Q36953719 | MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells |
| Q48266093 | Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells |
| Q49041875 | Modulation of P-glycoprotein in rat brain microvessel endothelial cells under oxygen glucose deprivation |
| Q35724624 | Myocyte growth in the failing heart |
| Q34503420 | Myocyte renewal and ventricular remodelling |
| Q28485257 | Nanoparticle mediated P-glycoprotein silencing for improved drug delivery across the blood-brain barrier: a siRNA-chitosan approach |
| Q44858867 | P-glycoprotein reduces the ability of amitriptyline metabolites to cross the blood brain barrier in mice after a 10-day administration of amitriptyline |
| Q45972266 | Platelet Endothelial Cell Adhesion Molecule-1 and Oligodendrogenesis: Significance in Alcohol Use Disorders. |
| Q34005678 | Pluronics and MDR reversal: an update. |
| Q48939114 | Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties |
| Q37224797 | Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection |
| Q35742284 | Reproducibility of quantitative (R)-[11C]verapamil studies |
| Q39988205 | Reversal of mdr1b-dependent multidrug resistance in a rat astrocyte model by adenoviral-delivered short hairpin RNA. |
| Q33186312 | Side population cells and Bcrp1 expression in lung. |
| Q52964010 | Synthesis and In Vivo Imaging of N-(3-[11C]Methoxybenzyl)-2-(3-Methoxyphenyl)ethylaniline as a Potential Targeting Agent for P-glycoprotein. |
| Q38899745 | The blood-brain barrier in Alzheimer's disease. |
| Q38856951 | Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies |
| Q42528307 | Transport of HIV-protease inhibitors across 1 alpha,25di-hydroxy vitamin D3-treated Calu-3 cell monolayers: modulation of P-glycoprotein activity |
| Q44173770 | Vascular endothelial growth factor is expressed in endothelial cells isolated from skeletal muscles of nitric oxide synthase knockout mice during prazosin-induced angiogenesis |
| Q35108868 | miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes |
Search more.